Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.31 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL54719 | 0.98 | ROCK2 (0.44) | ROCK2CYP3A4TDP1GAAALDH1A1 | |
| SCHEMBL301161 | 0.98 | ROCK2 (0.44) | ROCK2CYP3A4TDP1GAAALDH1A1 | |
| SCHEMBL301129 | 0.98 | ROCK2 (0.44) | ROCK2CYP3A4TDP1GAAALDH1A1 | |
| SCHEMBL2271458 | 0.95 | ROCK2 (0.43) | ROCK2CYP3A4TDP1GAAALDH1A1 | |
| SCHEMBL9516193 | 0.95 | ROCK2 (0.43) | ROCK2CYP3A4TDP1GAAALDH1A1 | |
| Bromide SCHEMBL8849424 | 0.95 | ROCK2 (0.43) | ROCK2CYP3A4TDP1GAAALDH1A1 | |
| SCHEMBL30727801 | 0.95 | ROCK2 (0.43) | ROCK2CYP3A4TDP1GAAALDH1A1 | |
| SCHEMBL9634618 | 0.95 | ROCK2 (0.43) | ROCK2CYP3A4TDP1GAAALDH1A1 | |
| SCHEMBL28530861 | 0.95 | ROCK2 (0.43) | ROCK2CYP3A4TDP1GAAALDH1A1 | |
| SCHEMBL301091 | 0.95 | CYP3A4 (0.39) | ROCK2CYP3A4TDP1ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9688604-B2 | Phosphine ligand and palladium catalysts based thereon for the alkoxycarbonylation of ethylenically unsaturated compounds | EVONIK DEGUSSA GMBH (DE) | 2017-06-27 | — | — | US | disclosed |
| CN-106687466-A | Method for producing ethylenedialkylphosphinic acids, esters and salts, and the use thereof as flame retardants | 科莱恩塑料和涂料有限公司 | 2017-05-17 | — | — | CN | disclosed |
| CN-103724372-B | The purposes of ethylene alkyl phosphinic acid, ethylene alkyl phosphinates and ethylene alkyl phosphinate | 科莱恩金融(BVI)有限公司 | 2017-03-01 | — | — | CN | disclosed |
| US-20170022236-A1 | FERROCENE-BASED COMPOUNDS AND PALLADIUM CATALYSTS BASED THEREON FOR THE ALKOXYCARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | EVONIK DEGUSSA GMBH (DE) | 2017-01-26 | — | — | US | disclosed |
| US-20170022234-A1 | PHOSPHINE LIGAND AND PALLADIUM CATALYSTS BASED THEREON FOR THE ALKOXYCARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | EVONIK DEGUSSA GMBH (DE) | 2017-01-26 | — | — | US | disclosed |
| EP-3121185-A2 | PHOSPHIN LIGAND AND PALLADIUM CATALYST BASED ON SAME FOR ALKOXYCARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | Evonik Degussa GmbH (DE) | 2017-01-25 | — | — | EP | disclosed |
| EP-2610248-B1 | METHOD FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE BY MEANS OF COUPLING METHOD USING A PALLADIUM COMPOUND | TEIJIN PHARMA LTD (JP) | 2016-06-08 | — | — | EP | disclosed |
| US-9243098-B2 | Compound, polymer, cross-linked compound of polymer, and optical element including cross-linked compound | CANON KABUSHIKI KAISHA (JP) | 2016-01-26 | — | — | US | disclosed |
| CN-102164934-B | Method for producing mono-hydroxy-functionalized dialkylphosphinic acids, esters and salts by means of ethylene oxide, and use thereof | CLARIANT FINANCE (BVI) LTD. (VG) | 2015-11-25 | — | — | CN | disclosed |
| CN-102186865-B | Method for producing dialkylphosphinic acids, esters and salts using acrylonitrile, and use thereof | CLARIANT FINANCE (BVI) LTD. (VG) | 2015-10-14 | — | — | CN | disclosed |
| WO-2007035540-A2 | PROCESS FOR THE MONOSULFONATION OF AROMATIC PHOSPHINES, AND ZWITTERIONIC PRODUCT DERIVED THEREFROM | DOW GLOBAL TECHNOLOGIES INC. (US) | 2007-03-29 | — | — | WO | disclosed |
| EP-0927577-B1 | Ruthenium metathesis catalyst and method for olefin metathesis using the same | TAKASAGO PERFUMERY CO LTD (JP) | 2004-06-23 | — | — | EP | disclosed |
| US-6313365-B1 | Ruthenium metathesis catalyst and method for producing olefin reaction product by metathesis reaction using the same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2001-11-06 | — | — | US | disclosed |
| US-6175047-B1 | A CATALYST MIXTURE INCLUDING A RUTHENIUM COMPOUND, A DIHALOGENO COMPOUND, A TERMINAL ALKYNE; AS A CATALYST FOR A CARBON-CARBON BOND FORMATION REACTION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2001-01-16 | — | — | US | disclosed |
| EP-0696474-B1 | Catalytic systems and methods for carbonylation | DAICEL CHEM (JP) | 2000-05-17 | — | — | EP | disclosed |
| EP-0948999-A1 | Catalytic systems and method for carbonylation | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1999-10-13 | — | — | EP | disclosed |
| EP-0927577-A1 | Ruthenium metathesis catalyst and method for producing olefin reaction product by metathesis reaction using the same | Takasago International Corporation (JP) | 1999-07-07 | — | — | EP | disclosed |
| US-5869738-A | OF AN OLEFIN WITH CARBON MONOXIDE PRODUCING AN ACID | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1999-02-09 | — | — | US | disclosed |
| US-5731255-A | GROUP VIII METAL SOURCE, LIGAND, ACID | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1998-03-24 | — | — | US | disclosed |
| EP-0696474-A2 | Catalytic systems and methods for carbonylation | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1996-02-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170022234-A1 | PHOSPHINE LIGAND AND PALLADIUM CATALYSTS BASED THEREON FOR THE ALKOXYCARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | PDCD1LG2, PDCD1, CD274 | ROCK2 2933/4885CYP3A4 1838/4885TDP1 2787/4885 |
| US-20170022236-A1 | FERROCENE-BASED COMPOUNDS AND PALLADIUM CATALYSTS BASED THEREON FOR THE ALKOXYCARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | C5, C1S, ALOX12 | ROCK2 1999/4885CYP3A4 1060/4885TDP1 4556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.